A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

By sjmartinez • February 7, 2024

Hammond TC, Purbhoo MA, Kadel S, Ritz J, Nikiforow S, Daley H, Shaw K, van Besien K, Gomez-Arteaga A, Stevens D, Ortuzar W, Michelet X, Smith R, Moskowitz D, Masakayan R, Yigit B, Boi S, Soh KT, Chamberland J, Song X, Qin Y, Mishchenko I, Kirby M, Nasonenko V, Buffa A, Buell JS, Chand D, van Dijk M, Stebbing J, Exley MA. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024 Feb 6;15(1):974. doi: 10.1038/s41467-024-44905-z. PMID: 38321023.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Closed-Loop Multimodal Neuromodulation of Vagus Nerve for Control of Heart Rate

Bender SA, Green DB, Kilgore KL, Bhadra N, Ardell JL, Vrabec TL. Closed-Loop Multimodal Neuromodulation of Vagus Nerve for Control of Heart Rate. Proc Am[...]

Ventricular Tachycardia Storm in a Young Adult Post-ALCAPA Repair

Jeong SY, Hayase J, Moore J, Bender A, Do D, Sanchez DR, Doris JM. Ventricular Tachycardia Storm in a Young Adult Post-ALCAPA Repair. JACC Case Rep.[...]

Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for[...]